Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Humane Cosmetics Act Lacks FDA Assurance Regarding Alternative Methods

Executive Summary

Available non-animal tests for substantiating cosmetic safety "by all appearances are valid," but questions remain as to whether FDA agrees, according to EAS Senior Advisor John Bailey. In the absence of agency guidance on alternative methods and a defined pathway for regulatory acceptance, some industry members are hesitant to get behind the proposed Humane Cosmetics Act in the U.S., the former FDAer suggested in an interview.

Advertisement

Related Content

Humane Society Gears Up For Renewed Push Behind U.S. Animal-Test Ban
U.S. Or China? Humane Cosmetics Act Could Force Multinationals To Choose
Industry May Lean On Outside Animal Data If Humane Cosmetics Act Passes
ICCR Addresses Lead Limit, Endocrine Disruptors At 7th Meeting
NICEATM Readies 5-Year Plan For Congress; Director Stokes Discusses
Advertisement
UsernamePublicRestriction

Register

RS019605

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel